Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michela Muraro"'
Autor:
Michela Muraro, Cristina Cravero, O.M. Mereuta, Franca Fagioli, Francesco Saglio, Francesca Carraro
Publikováno v:
Cellular Immunology. 266:123-129
The expression of tumor associated antigens (TAA) in osteosarcoma cell lines allowed us to design an in vitro model for the generation of TAA-specific CTLs. Since the MHC-I-restriction of these peptides represents the major obstacle to clinical appli
Publikováno v:
Cellular Immunology. 249:63-72
Bisphosphonates have a profound effect on bone resorption and are widely used in the treatment of osteoclast-mediated bone diseases. Zoledronic acid (ZA), a third-generation biphosphonate, has a potent antitumor activity and expands gammadelta (gamma
Autor:
Sara Castiglia, Massimiliano Bergallo, Michela Muraro, Fiorella Sanavio, Deborah Rustichelli, Franca Fagioli, Katia Mareschi, Davide Defedele
Publikováno v:
Experimental hematology. 44(2)
Mesenchymal stromal cells (MSCs) are a promising tool in cell therapies because of their multipotent, bystander, and immunomodulatory properties. Although bone marrow represents the main source of MSCs, there remains a need to identify a stem cell so
Autor:
Elena Signorino, Michela Muraro, Deborah Rustichelli, Monica Gunetti, Katia Mareschi, Ivana Ferrero, Fiorella Sanavio, Sara Castiglia, Laura Castello, Franca Fagioli
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss 1, p 112 (2012)
Journal of Translational Medicine, Vol 10, Iss 1, p 112 (2012)
Background The quality and safety of advanced therapy products must be maintained throughout their production and quality control cycle to ensure their final use in patients. We validated the cell count method according to the International Conferenc
To the Editor: There have been few reports of osteosarcoma after allogeneic bone marrow transplantation.1 We report the development of osteosarcoma in a recipient 17 years after stem-cell transplantation. A 23-month-old boy with β-thalassemia receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8159eda432916c9190c9a5904ab5f75
http://hdl.handle.net/2318/1690755
http://hdl.handle.net/2318/1690755
Autor:
Franca Fagioli, Francesca Carraro, Massimo Berger, Enrico Madon, Francesco Saglio, Michela Muraro, O.M. Mereuta
Dendritic cells (DCs) might be partly responsible for the defective immune response in tumor bearing hosts, but no study in osteosarcoma patients is still available. Therefore, we investigated in vitro whether human osteosarcoma cell lines have an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a63fb8c6a9ba382bbe1f8a02c4e5117
http://hdl.handle.net/2318/1690801
http://hdl.handle.net/2318/1690801
Autor:
Mario Boccadoro, Sara Mariani, Marta Coscia, F. Fiore, Barbara Nuschak, Myriam Foglietta, Massimo Massaia, Silvia Peola, Benedetto Bruno, Michela Muraro
The aim of this work was to investigate the interactions of tumor cells with dendritic cells (DC) in normal donors and patients with multiple myeloma (MM). Normal and MM DC internalized necrotic lysates derived from myeloma cell lines (MCL) with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddadb4cceb5848fd555d23ce3ebeb821
http://hdl.handle.net/2318/40461
http://hdl.handle.net/2318/40461
Autor:
Sara Castiglia, Laura Castello, Deborah Rustichelli, Franca Fagioli, Ivana Ferrero, Marco Leone, Fiorella Sanavio, Elena Signorino, Michela Muraro, Katia Mareschi, Monica Gunetti
Publikováno v:
Journal of Translational Medicine
Background The quality and safety of cell therapy products must be maintained throughout their production and quality control cycle, ensuring their final use in the patient. We validated the Lymulus Amebocyte Lysate (LAL) test and immunophenotype acc